Scholars Central

Research articlePublished 18 Apr 2022

D-dimer as a Predictive Marker for COVID-19 Severity

Authors: Harfouch RM

Journal of Chemical and Pharmaceutical Research

Volume 14 · Issue 2 · Pages 06–09

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) caused Coronavirus Disease 2019 (COVID-19), which was first recorded in Wuhan, China in December 2019. COVID-19 is primarily a respiratory infection, but it can also affect multiple organ systems including cardiac, neurological, gastrointestinal and renal systems. D-dimer is a fibrin degradation product, which is used as a biomarker for thrombotic disorders. It is considered normal with values less than 0.5 μg/mL, and the level of D-dimer rises in severe community-acquired pneumonia, it is also used as an initial screening test to diagnose patients who have signs, or symptoms suggestive of venous thromboembolism

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Chemical and Pharmaceutical Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Chemical and Pharmaceutical Research
  • SubjectPharmaceutical Sciences
  • SubjectChemistry
  • BylineArticles whose byline prints “Harfouch RM”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels